Korean J Pediatr Hematol Oncol.  2005 Apr;12(1):131-137.

A Case of Langerhans Cell Histiocytosis with Hypothalamic Mass

Affiliations
  • 1Department of Pediatrics, College of Medicine, Kosin University, Busan, Korea. pjs@ns.kosinmed.or.kr
  • 2Department of Pathology, College of Medicine, Kosin University, Busan, Korea.
  • 3Department of Diagnostic Radiology, College of Medicine, Kosin University, Busan, Korea.
  • 4Department of Radiation Oncology, College of Medicine, Kosin University, Busan, Korea.

Abstract

A 14-month-old girl presented with petechial skin lesions and polydipsia was diagnosed as Langerhans cell histiocytosis (LCH) and responded fairly well to multiple chemotherapies using vincristine, cyclophosphamide, and prednisone. 3 years later, relapses were more common with short periods of remissions in spite of using more intensive therapy with vinblatine and etoposide. At age of 4.5, sudden weight gain and abnormal behavior led to MRI study and revealed an hypothalamic mass. Radiation of 1, 800 cGy was given to the mass and followed by a 75% decrease in measuring and remission of the obesity. Although, there was no evidence of tumor progression in the hypothalamus, she died of sepsis due to systemic progression of the disease at age of 5. LCH commonly present with the symptoms of diabetes insipidus, but hypothalamic mass is not common. We report this case with a brief review of literatures.

Keyword

Langerhans cell histiocytosis; Hypothalamic mass; Radiation

MeSH Terms

Cyclophosphamide
Diabetes Insipidus
Drug Therapy
Etoposide
Female
Histiocytosis, Langerhans-Cell*
Humans
Hypothalamus
Infant
Magnetic Resonance Imaging
Obesity
Polydipsia
Prednisone
Recurrence
Sepsis
Skin
Vincristine
Weight Gain
Cyclophosphamide
Etoposide
Prednisone
Vincristine
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr